The company on Sunday said that continued use of its weight management drug semaglutide, sold to consumers as Wegovy, led to a 57% greater reduction in the risk of heart attack, stroke or death in people with obesity and cardiovascular disease or who were overweight, compared with users of tirzepatide
However, no significant resolution of the FIB-4 was observed
Another option to get Wegovy is on Ro
Additionally, Elders expects that you will use your knowledge, experience and best judgement in relying on any recommendation and determining whether the recommendation is, and continues to be, appropriate
looked at female patients diagnosed with ovarian cancer between 2014 and 2023 and split them into two groups based on GLP-1RA exposure: users vs non-users
Supporting Information Acknowledgments We thank Miao-Mei Chen and all colleagues at Branch of Linsen and Chinese Medicine, Taipei City Hospital, Taiwan, for their help with this study